Related Articles
Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer
Upregulation of Holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer
miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
Overexpression levels of cripto‑1 predict poor prognosis in patients with prostate cancer following radical prostatectomy
FOXL1 overexpression is associated with poor outcome in patients with glioma